Cost-Effectiveness Analysis of Atezolizumab Compared To The Standard of Care For The Treatment of Adult Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy in Greece

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.233
https://www.valueinhealthjournal.com/article/S1098-3015(17)30567-3/fulltext
Title : Cost-Effectiveness Analysis of Atezolizumab Compared To The Standard of Care For The Treatment of Adult Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy in Greece
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30567-3&doi=10.1016/j.jval.2017.08.233
First page : A439
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 216
Categories :
Tags :
Regions :
ViH Article Tags :